Terlipressin Acetate NEW
| Price | $41 | $56 | $105 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-07-29 |
Product Details
| Product Name: Terlipressin Acetate | CAS No.: 1884420-36-3 |
| Purity: 99.69% | Supply Ability: 10g |
| Release date: 2025/07/29 |
Product Introduction
Bioactivity
| Name | Terlipressin Acetate |
| Description | Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research. |
| In vitro | Incubation with 25 nM terlipressin significantly improved cell viability, proliferation and apoptosis. Furthermore, terlipressin inhibited the secretion of TNF-α and 15-F2t-isoprostane from IEC-6 cells following OGD/R[1]. |
| In vivo | Using a mouse nonlethal hepatic IR model, we found terlipressin administration significantly ameliorated IR-induced liver apoptosis, necrosis and inflammation[2]. |
| Storage | keep away from moisture,store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 95 mg/mL (70.5 mM), Sonication is recommended. |
| Keywords | VasopressinReceptor | vasopressin V1 | Vasopressin Receptor | vasoconstriction | variceal | V1-receptors | Terlipressin Acetate | Terlipressin | bleeding | anti-oxidative |
| Inhibitors Related | Atosiban acetate | OPC-51803 | Felypressin acetate | Balovaptan | d[Cha4]-AVP acetate(500170-27-4 free base) | Nelivaptan | TASP0390325 | d[Leu4,Lys8]-VP acetate | E-4177 | Fuscoside | Conopressin S acetate(111317-90-9 free base) | Tolvaptan |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Cyclic Peptide Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Peptide Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $85.00/1KG |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2023-11-02 | |
| $0.00/10mg |
VIP1Y
|
Moxin Chemicals
|
2025-03-13 | |
| $1.00/1g |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2024-03-26 | |
| $41.00/5mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-01 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY